Barry Shin
Chief Financial OfficerMr. Barry Shin, J.D., M.B.A., serves as Chief Financial Officer at Compass Therapeutics, Inc. since December 09, 2024. He served as Chief Operating Officer of Trevena, Inc. since February 2, 2024 and served as its Executive VP from February 01, 2024 until November 26, 2024 and had been its Chief Financial Officer since June 25, 2019 until November 26, 2024 and served as its Senior Vice President until February 2, 2024. Mr. Shin joined Trevena, Inc. since June 2019. He served as Vice President of Guggenheim Securities, LLC since August 2012. Mr. Shin joins Trevena with extensive experience advising biopharmaceutical companies through merger and acquisition (M&A) and financing transactions. He was previously Managing Director in the Healthcare Investment Banking Group at Mizuho Securities from May 2017 until he joined the Company. Prior to joining Mizuho Securities, he was a Managing Director in Guggenheim Securities’ Healthcare Investment Banking Group from May 2012 to May 2017. From 2005 to 2012, he served in positions of increasing responsibility within the Healthcare Investment Banking Group of Piper Jaffray. From 2001 to 2005, he advised healthcare and technology companies in financing and M&A transactions as a corporate attorney. Mr. Shin received a B. Sc. and joint JD / MBA from the University of Toronto.
Positions
- Company NameCompass Therapeutics, Inc.Stock CodeCMPXPositionChief Financial OfficerColleagues
- TJThomas J. SchuetzCEO & Vice Chairman
- CLCarl Lee GordonIndependent Chairman
- JEJonathan E. AndermanSenior VP, General Counsel & Corporate Secretary
- NLNeil L. LernerSenior VP & Chief Accounting Officer
- BGBing GongChief Scientific Officer
- PJPhilip J. FerneauIndependent Director
- RSRichard S. LindahlIndependent Director
- FSF. Stephen HodiMember of Clinical Advisory Board
